Declaration of the Non-Aligned Movement Labour Ministers
The Ministers of Labour of the Non-Aligned Movement (NAM) reflected on the progress made regarding fundamental labour principles and rights, on the occasion of the centenary of the International Labour Organization (ILO) (more...)
Legitimacy Concerns of the Proposed Multilateral Investment Court: Is Democracy Possible?By José Manuel Alvarez Zárate
Growing concerns in Europe about international investment regimes and investor-state dispute settlement systems pushed the European Union into (more...)
Intellectual Property and Electronic Commerce: Proposals in the WTO and Policy Implications for Developing CountriesBy Vitor Ido
This policy brief explains the mandate of the World Trade Organization (WTO) on electronic commerce under the work program on e-commerce, which was (more...)
South Centre Statement on Access to Biosimilars/Biogeneric Medicines at the WHA 72
The revision of the guidelines on similar therapeutic products mandated by Resolution WHA67.21 is crucial for promoting the availability of and access to biosimilars. The reduction in prices (more...)
Declaration of the XII Ministerial Meeting of the Ministers of Health of the Non-Aligned Movement (NAM), “Universal Health Coverage: Leave no one behind”
The Non-Aligned Movement (NAM) Health Ministers noted that making progress on Universal Health Coverage (more...)
South Centre Statement at the Meeting of the Non-Aligned Movement (NAM) Health Ministers
Dr. Carlos Correa, Executive Director of the South Centre, stressed the need to preserve the World Health Organization (WHO) as a public, independent agency that effectively addresses the (more...)
Colombia's Biogenerics Regulation A Preliminary Court Decision in favour of Public HealthBy Carolina Gómez
The Council of State of Colombia’s recent ruling on the abbreviated pathway for marketing authorization of biogenerics is a valuable step towards acceptance (more...)
The US-Mexico-Canada Agreement: Putting Profits Before PatientsBy Maria Fabiana Jorge
In the US-Mexico-Canada Agreement (USMCA, NAFTA 2.0), the U.S. Trade Representative negotiated intellectual property provisions related to pharmaceuticals that would enshrine long and (more...)
Title: How will the post BAPA+40 era further contribute to the attainment of the 2030 Agenda?
Date: 23 May 2019, 10h00 to 13h00
Venue: Room XIV (Door A-18, first floor), Palais des Nations, Geneva
Organizers: South (more...)